Shanghai Fosun Pharmaceutical Group Co Ltd financial statements, including revenue, expenses, profit, and loss

The total revenue of SFOSF for the last semiannual is 2.76 B USD, and it's 10.35% lower compared to the previous semiannual. The net income of H2 23 is 85.06 M USD.